Customer Access

E-Eye IPL, treatment for dry eyes - Featured on A Current Affair (Channel 9)

Dry-Eye syndrome treatment due to Meibomian Gland Dysfunction (MGD):

Introduced as one of the best French innovations at OMDA 2013 in Brisbane and SILMO 2013 Expo in Paris, the E>Eye Medical Grade IPL device is the first and only Intense Pulsed Light (IPL) device in the world, specifically designed for the treatment of dry eye syndrome due to the Meibomian Glands Dysfunction (MDG).

100% developed and made in France by E-Swin, the world largest IPL device manufacturer, the E>Eye is a revolutionary solution now available in New Zealand and TGA registered (ARTG #216 880) in Australia.

Ask for a demo today to discover a world innovation at last available for all ophthalmologists and optometrists. and opticians?


Stimulation of Meibomian glands

Stimulation of Meibomian Glands

About 80 Meibomian cells are located on the upper and lower eyelids. These cells produce a lipid called meibum which is a fat phase. Its role is to avoid the tears evaporation, adapting the tears to the irregularities of the eye surface and adapting a perfectly convex dioptre.

Applying four specific pulses with the E>Eye IPL from the external canthus to the internal canthus will, by innervation, stimulate and block the Meibomian glands which will return to their normal functions.
As a result the dry lipid layer will have a natural flow of lipid and the tears evaporation will be reduced, stopping the eyes to get dry.

The benefits are multiple: It improves the comfort of wearing contact lenses, reliefs pain from watching computers and other screens, reduces redness of the eye, etc…

France Medical Blog